U.S. market Closed. Opens in 1 day 6 hours 2 minutes

LEGN | Legend Biotech Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue285.14M117.00M89.79M75.68M57.26M49.13M23.59M
Cost of Revenue144.21M65.36M313.35M232.16MN/AN/A-96.00K
Gross Profit140.93M51.64M-223.55M-156.48M57.26M49.13M23.69M
Operating Expenses140.93M509.70M462.83M304.88M192.63M64.20M9.60M
Selling, General & Admin200.93M174.05M149.48M72.72M32.37M3.93M1.40M
Research & Development382.22M335.65M313.35M232.16M161.94M60.64M8.20M
Other Operating ExpensesN/A2.23M-6.07M-74.21M-1.68M-2.00KN/A
Operating Income-439.49M-455.83M-393.02M-313.35M-130.87M-1.53M13.78M
Other Expenses / Income-80.63M10.10M-14.17M-78.41M5.00M13.46M-40.00K
Before Tax Income-520.12M-445.72M-386.21M-307.62M-130.37M-1.62M13.84M
Income Tax Expenses-1.86M625.00K1.00K-4.14M2.60M1.17M4.47M
Net Income-518.25M-446.35M-386.21M-303.48M-132.97M-2.78M9.37M
Interest Expenses21.79M10.80M900.00K4.21M223.00K82.00KN/A
Basic Shares Outstanding176.08M159.04M140.85M118.15M132.01M100.00M132.01M
Diluted Shares Outstanding176.08M159.04M140.85M118.15M132.01M100.21M132.01M
EBITDA-477.87M-416.54M-392.38M-294.14M-124.89M149.00K14.06M
EBITDA Margin-167.59%-356.00%-436.99%-388.69%-218.09%0.30%59.57%
EBIT-498.32M-434.93M-385.31M-303.41M-130.15M-1.53M13.84M
EBIT Margin-174.76%-371.72%-429.11%-400.94%-227.28%-3.12%58.65%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙